AURORA SPINE CORPORATIONAA

AURORA SPINE CORPORATION

0.290CADD
+0.005+1.75%
At close at May 28, 18:47 GMT
CAD
No trades
See on Supercharts

ASG fundamentals

Key facts

Market capitalization‪22.64 M‬CAD
Basic EPS (TTM)−0.02CAD
Founded
CEOTrent J. Northcutt
About

Aurora Spine Corp. engages in the development and distribution of spinal implant products. Its products include interspinous process (ISP) lumbar fusion devices, polyether ether ketone interbody cages, and stand-alone cervical and lumbar cages. The company was founded by Trent J. Northcutt and Laszlo Garamszegi on 4th July, 2013 and is headquartered in Toronto, Canada.

Ownership
‪‪78.06 M‬‬
Free Float shares
‪‪58.78 M‬‬ (75.3%)
Closely held shares
‪‪19.28 M‬‬ (24.7%)
Free Float shares
‪‪58.78 M‬‬ (75.3%)
Closely held shares
‪‪19.28 M‬‬ (24.7%)
Capital structure
Market cap
‪‪22.64 M‬‬
Debt
‪‪3.65 M‬‬
Cash & equivalents
‪‪703.35 K‬‬
Enterprise value
‪‪25.58 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪22.64 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.89x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
0.89x
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25

Growth and Profitability

Company’s recent performance and margins

Performance
‪−15%‬
‪−10%‬
‪−5%‬
‪0%‬
‪5%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−2.50 M‬‬
‪0.00‬
‪‪2.50 M‬‬
‪‪5.00 M‬‬
‪‪7.50 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−2.20 M‬‬
‪0.00‬
‪‪2.20 M‬‬
‪‪4.40 M‬‬
‪‪6.60 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−2.20 M‬‬
‪0.00‬
‪‪2.20 M‬‬
‪‪4.40 M‬‬
‪‪6.60 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Hospitals and Ambulatory Surgery Centers
Distributors
Commissions
By country
Period: 2024
United States

Dividends

Dividend yield, history and sustainability

No dividends
ASG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−1.30 M‬‬
‪0.00‬
‪‪1.30 M‬‬
‪‪2.60 M‬‬
‪‪3.90 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪3.50 M‬‬
‪‪7.00 M‬‬
‪‪10.50 M‬‬
‪‪14.00 M‬‬
Assets
Liabilities